Prof. Carina Baer de Oliveira Mann
Technical University of Munich, Germany
Cellular Biotechnology & Translational Research
Open international conference • Abstract submissions • Registration open
|
Dates: 09–11 June 2027
|
Venue: Barcelona, Spain
Open conference • Biotechnology • Pharma Innovation • Industry Partnerships
20th Congress on Biotechnology & Pharmaceutical Innovation
EICBPI 2027 brings together researchers, academics, biotechnology and pharmaceutical scientists, clinicians, students, translational researchers, biomanufacturing professionals, regulatory specialists, innovators, investors, and industry participants for scientific exchange, research presentations, collaboration, and professional networking.
Venue
Barcelona
Spain
Dates
09–11 June 2027
3-day international conference
Format
Open conference
Curated access to protect relevance and trust.
Outcome
Research & Industry Impact
Built for research exchange, partnerships, innovation, translation, licensing and industry collaboration.
Congress overview
An open international conference connecting biotechnology, pharmaceutical sciences, translational research, manufacturing, regulation, innovation and industry.
Dates
09–11 June 2027
Location
Barcelona, Spain
See host location details on the Host Location page
Participation model
Submit Abstract → Review → Register
Non-presenting delegates may register directly
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Conference experience
Roundtables • professional networking • outcome-driven sessions
Key dates
Important milestones for abstract submission, review, registration and conference participation.
Abstract submission
31 October 2026
Notification
Within 7–10 days of submission
Registration
20 November 2026
Congress dates
09–11 June 2027
Note: Abstracts are reviewed after submission. Accepted presenters should complete registration to confirm participation; non-presenting delegates may register directly.
Why attend EICBPI 2027
A multidisciplinary conference programme designed for scientific exchange, translational research, clinical and manufacturing perspectives, collaboration, licensing dialogue, professional networking and industry engagement across biotechnology and pharmaceutical innovation.
Open participation
Attendance is relevance-first to protect participant time and trust.
Apply → abstract review
Closed-door roundtables
Facilitated conversations focused on strategic partnerships and real next steps.
Outcome notes & next steps
Partner matchmaking
Introductions aligned to licensing, investment, manufacturing, and market access goals.
High-trust networking
Premium support
Invoices, documentation support, and delegate assistance.
Email: participation@executivecongresses.com
Featured Keynote Speakers
Selected keynote speakers contributing expertise across biotechnology, pharmaceutical innovation, molecular biology, translational medicine, immunology, bioanalysis, and advanced therapeutic development.
Dr Nicola Baker
University of York, United Kingdom
Translational Biotechnology & Therapeutic Innovation
Professor Wei LU
Biotechnology Research Institute, CAAS, China
Agricultural Biotechnology & Applied Bioinnovation
Prof Paul Moynagh
National University of Ireland, Ireland
Inflammation Biology & Drug Discovery Strategy
Prof Iris BEHRMANN
University of Luxembourg
Cytokine Signalling & Precision Therapeutics
Professor Saulius Klimašauskas
Vilnius University, Lithuania
Epigenetic Technologies & Molecular Tools
Dr Sara Anjomani Virmouni
Brunel University London, United Kingdom
Neurogenetics & Molecular Medicine
Prof. Dr. Julia Schulze-Hentrich
Saarland University, Germany
Epigenomics, Systems Biology & Biotech Innovation
Professor Dieter Deforce
University of Ghent, Belgium
Pharmaceutical Biotechnology & Forensic Genomics
Sponsors & Industry Supporters
EICBPI 2027 recognises organisations contributing to biotechnology, pharmaceutical innovation, diagnostics, therapeutic development, manufacturing, clinical translation, and life-science industry growth.
Abivax
Clinical-stage biotechnology company advancing immune-modulating therapies for inflammatory and infectious disease areas.
argenx
Global immunology company developing antibody-based medicines for severe autoimmune diseases.
BioNTech
Biotechnology company known for mRNA platforms, immunotherapies, and next-generation precision medicine.
Cellectis
Genome engineering and cell therapy innovator focused on allogeneic CAR-T and therapeutic platforms.
Eurofins
International laboratory services group supporting bioanalytical testing, genomics, clinical diagnostics, and pharmaceutical quality.
Evotec
Drug discovery and development partner supporting integrated research, translational platforms, and precision medicine programs.
Genmab
Biotechnology company developing differentiated antibody therapeutics for oncology and serious diseases.
Ipsen
Global biopharmaceutical company focused on oncology, rare disease, and neuroscience therapies.
ITM
Radiopharmaceutical biotechnology company advancing targeted radionuclide therapies and precision oncology solutions.
Lonza
Global manufacturing partner for pharma, biotech, biologics, cell therapy, and advanced therapeutic development.
QIAGEN
Provider of molecular diagnostics, sample technologies, assay platforms, and life science research solutions.
Verdiva Bio
Clinical-stage biopharmaceutical company focused on next-generation therapies for obesity and metabolic disorders.
Themes & focus areas
Clear themes help delegates assess relevance quickly and support high-quality proposals.
Biotechnology Platforms
Cell and gene technologies, molecular platforms, synthetic biology, and translational biotech innovation.
Drug Discovery & Development
Target discovery, preclinical development, translational science, and clinical development strategy.
Pharmaceutical Innovation
Novel therapeutics, delivery platforms, formulation science, and future pharma pipelines.
Bioprocessing & Manufacturing
Scale-up, biologics manufacturing, process optimization, CDMO strategy, and quality systems.
Regulatory, Compliance & Market Access
Regulatory pathways, reimbursement, compliance frameworks, pharmacovigilance, and launch planning.
Licensing, Investment & Partnerships
Strategic alliances, licensing models, venture collaboration, portfolio value, and deal-making.
Digital Biotech & AI in Pharma
AI-assisted discovery, data-driven R&D, digital labs, automation, and translational analytics.
Clinical Translation & Commercial Readiness
Bridging research to patient impact, scalable delivery models, and commercialization planning.
Global Supply, Resilience & Strategy
Supply chain resilience, site strategy, cross-border growth, and strategic risk management.
Agenda at a glance
A clear conference programme across three days — structured time blocks for roundtables, keynotes, strategic exchange, and commercial outcomes.
How participation works
EICBPI 2027 follows an open conference model. Presenters submit an abstract for review, while non-presenting delegates may register directly.
Step 01
Apply to attend
Share role, organisation, and objectives.
Step 02
Confirmation
Abstract review and confirmation email.
Step 03
Secure participation
Invoice support and registration completion.
Need an invoice or quick call?
We can support invoices, participation confirmation, documentation and sponsor/exhibitor enquiries.
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Host location
Venue details, access, and local guidance
Venue & access
All host location information is consolidated for clarity — access routes, recommended stays, and local tips.
City
Barcelona, Spain
Host location
View venue details